Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Pharm Biol ; 48(6): 615-20, 2010 Jun.
Article de Anglais | MEDLINE | ID: mdl-20645733

RÉSUMÉ

The essential oils of Croton heliotropiifolius Kunth (Euphorbiaceae) and Croton pulegiodorus Baill. were selected for larvicidal evaluation against Aedes aegypti L. (Diptera: Culicidae) and studied qualitatively and quantitatively by GC and GC-MS. Sixty-one compounds representing 92.03% (C. heliotropiifolius) and 85.68% (C. pulegiodorus) of the essential oils, respectively, have been identified. The major components of C. heliotropiifolius essential oil were identified as beta-caryophyllene (35.82%), bicyclogermacrene (19.98%), and germacrene-D (11.85%). The major components in C. pulegiodorus essential oil were identified as beta-caryophyllene (20.96%), bicyclogermacrene (16.89%), germacrene-D (10.55%), tau-cadinol (4.56%), and beta-copaen-4-alpha-ol (4.35%). The essential oil of C. pulegiodorus (LC50 159 ppm) was more effective against Ae. aegypti than that of C. heliotropiifolius (LC50 544 ppm). In order to verify whether the major compound of both essential oils is the active principle responsible for the larvicidal activity, beta-caryophyllene was purchased and its larvicidal potential was further evaluated. However, beta-caryophyllene (LC50 1038 ppm) showed weak larvicidal potency. Results of larvicidal evaluation suggest the existence of a synergistic effect of minor components in the essential oils.


Sujet(s)
Aedes , Croton/composition chimique , Insecticides/pharmacologie , Huile essentielle/pharmacologie , Animaux , Brésil , Synergie des médicaments , Chromatographie gazeuse-spectrométrie de masse , Insecticides/composition chimique , Insecticides/isolement et purification , Larve , Dose létale 50 , Lutte contre les moustiques/méthodes , Huile essentielle/composition chimique , Huile essentielle/isolement et purification , Huiles végétales/composition chimique , Huiles végétales/isolement et purification , Huiles végétales/pharmacologie , Spécificité d'espèce
2.
J Neural Transm Gen Sect ; 91(2-3): 111-34, 1993.
Article de Anglais | MEDLINE | ID: mdl-8099795

RÉSUMÉ

A unique model of DA system regulation is presented, in which tonic steady-state DA levels in the ECF act to down-regulate the response of the system to pulsatile DA released by DA cell action potential generation. This type of regulation is similar in many respects to the phenomenon proposed to mediate the action of norepinephrine on target neurons; i.e., an increase in the "signal-to-noise" ratio as measured by postsynaptic cell firing (Freedman et al., 1977; Woodward et al., 1979). However, in this model the signal and the noise are neurochemical rather than electrophysiological. Furthermore, the "noise" (tonic DA in the ECF) actually down-regulates the "signal" (phasic DA release) directly, and thereby provides a "signal" of its own that affects the system over a longer time-course. Therefore, the difference between signal and noise may also depend on the time frame under which such determinations are made.


Sujet(s)
Cortex cérébral/physiologie , Dopamine/physiologie , Modèles neurologiques , Schizophrénie/physiopathologie , Voies afférentes , Animaux , Neuroleptiques/pharmacologie , Cognition/physiologie , Corps strié/physiologie , Modèles animaux de maladie humaine , Antagonistes de la dopamine , Espace extracellulaire/métabolisme , Rétroaction , Humains , Modèles psychologiques , Noyau accumbens/physiologie , Rats , Récepteurs dopaminergiques/effets des médicaments et des substances chimiques , Récepteurs dopaminergiques/physiologie , Psychologie des schizophrènes , Synapses/métabolisme , Transmission synaptique/effets des médicaments et des substances chimiques
3.
J Neural Transm Suppl ; 36: 91-131, 1992.
Article de Anglais | MEDLINE | ID: mdl-1356143

RÉSUMÉ

Antipsychotic drugs are known to block dopamine receptors soon after their administration, resulting in an increase in dopamine neuron firing and dopamine turnover. Nonetheless, antipsychotic drugs must be administered repeatedly to schizophrenics before therapeutic benefits are produced. Recordings from dopamine neurons in rats have revealed that chronic antipsychotic drug treatment results in the time-dependent inactivation of dopamine neuron firing via over-excitation, or depolarization block. Furthermore, the clinical profile of the response to antipsychotic drugs appears to correspond to the dopamine system affected: antipsychotic drugs that exert therapeutic actions in schizophrenics inactivate dopamine neuron firing in the limbic-related ventral tegmental area, whereas drugs that precipitate extrapyramidal side effects cause depolarization block of the motor-related substantia nigra dopamine cells. One factor that remains unresolved with regard to the actions of antipsychotic drugs is the relationship between dopamine turnover and depolarization block--i.e., why does a significant level of dopamine release or turnover remain after antipsychotic drug treatment if dopamine cells are no longer firing? We addressed this question using an acute model of neuroleptic-induced depolarization block. In this model, dopamine cells recorded in rats one month after partial dopamine lesions could be driven into depolarization block by the acute administration of moderate doses of haloperidol. However, similar doses of haloperidol, which were effective at increasing dopamine levels in the striatum of intact rats, failed to change dopamine levels in lesioned rats. This is consistent with a model in which neuroleptic drugs exert their therapeutic effects in schizophrenics by causing depolarization block in DA cells, thereby preventing further activation of dopamine neuron firing in response to external stimuli. Thus, attenuating the responsivity of the dopamine system to stimuli may be more relevant to the therapeutic actions of antipsychotic drugs than receptor blockade or decreases in absolute levels of dopamine, which could presumably be circumvented by homeostatic adaptations in this highly plastic system.


Sujet(s)
Neuroleptiques/pharmacologie , Schizophrénie/traitement médicamenteux , Dopamine/métabolisme , Tractus extrapyramidaux/effets des médicaments et des substances chimiques , Humains , Potentiels de membrane/effets des médicaments et des substances chimiques , Modèles neurologiques , Neurones/effets des médicaments et des substances chimiques , Schizophrénie/étiologie , Schizophrénie/physiopathologie
4.
Neurosci Lett ; 96(1): 82-8, 1989 Jan 02.
Article de Anglais | MEDLINE | ID: mdl-2494609

RÉSUMÉ

The effects of the antipsychotic drug haloperidol (HAL) on the electrophysiological activity of dopamine (DA)-containing cells in the substantia nigra was assessed in rats 6 weeks after partial 6-hydroxydopamine (6-OHDA)-induced lesions of the nigrostriatal DA pathway. Depleting 75% or more of striatal DA altered the response of DA neurons to acute HAL administration. Whereas acute HAL administration generally accelerates DA neuron firing in control rats, similar HAL doses given to lesioned rats not only increased firing rate but induced depolarization block of DA neuron spike generation similar to that resulting from chronic neuroleptic administration. In contrast, acute administration of doses of HAL up to lethal levels typically could not induce depolarization block of DA neurons in non-lesioned rats. This preparation thus could be an effective model for investigating the exacerbation of behavioral deficits produced by an increased demand placed upon a compromised DA system, as may occur in Parkinson's disease or with antipsychotic drug treatment.


Sujet(s)
Halopéridol/pharmacologie , Hydroxydopamines , Substantia nigra/physiologie , Potentiels d'action/effets des médicaments et des substances chimiques , Animaux , Relation dose-effet des médicaments , Mâle , Oxidopamine , Rats , Lignées consanguines de rats , Substantia nigra/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE